Načítá se...
BRAF V600E Mutation Is Associated with mTOR Signaling Activation in Glioneuronal Tumors
BRAF V600E mutations have been recently reported in glioneuronal tumors (GNTs). To evaluate the expression of the BRAF V600E mutated protein and its association with activation of the mammalian target of rapamycin (mTOR) pathway, immunophenotype and clinical characteristics in GNTs, we investigated...
Uloženo v:
| Vydáno v: | Brain Pathol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8029322/ https://ncbi.nlm.nih.gov/pubmed/23941441 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bpa.12081 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|